Scientists discover novel compound to combat age-related blindness

Rensselaer Polytechnic Institute’s Christopher Cioffi, Ph.D., Thomas and Constance D’Ambra Professor in Organic Chemistry, has been collaborating with Konstantin Petrukhin, Ph.D., Professor of Ophthalmic Science at Colombia University, to develop compounds to treat dry age-related macular degeneration (AMD) and Stargardt disease – both blindness-causing diseases.

What Does the White House Drug Czar’s New Plan Target?

The 24-hour news cycle is just as important to medicine as it is to politics, finance, or sports. At MedPage Today, new information is posted

July 17, 2023

Brain’s immune cells may be a key target for preventing cognitive deficits after radiation exposure

Researchers at the Del Monte Institute for Neuroscience at the University of Rochester find that microglia-;the brain’s immune cells-;can trigger cognitive deficits after radiation exposure

January 3, 2024

Q&A: Gilead public affairs chief on new strategy, TikTok, and why the company won’t ‘keep doing things the same way’

After years of quiet focus on HIV and virology and stoic responses to flare-ups of attention over its pricing decisions, the new Gilead Sciences is

September 20, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.